Placebo Effects Flashcards

1
Q

What is a complimentary therapy?

A
  • A heterogeneous group of therapies that share a focus on, or integration of, treatment of mind and spirit as well as body (Franck et al., 2007)
  • Often focus on symptom relief or prevention rather than cure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Give 2 examples of complementary therapies

A
  • Accupuncture
  • Aromatherapy
  • Cupping
  • Herbal Medicine
  • Yoga
  • Reiki
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Complementary therapies are much less researched than mainstream medicine. Does absence of evidence indicate evidence of absence?

A
  • What if complementary therapies show no clinical effects but improve wellbeing.
  • i.e. Physical Activity for treatment of depression vs obesity! Evidence base varies hugely.
  • Should still be used by indivdual if not doing physical harm, and they are gaining benefit from it in anyway
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Why are complementary therapies not widely offered on the NHS

A
  • Can help relieve pain/discomfort
  • But limited resources/funding from the NHS- other services more important to fund
  • Evidence base weak!
  • Available privately
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Define a placebo

A
  • Treatment effects of remedies that are not understood to have any direct link to the outcome.
  • Placebo effects mimic drug effects (e.g. pain relief).
  • Can also mimic drug side effects (e.g. nausea) – nocebo.
  • Placebo effects can be very powerful!
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the 1996 McQuay systematic review on placebos

A
  • Five placebo-controlled RCTs
  • Acute postoperative pain (130 out of 525 had placebo).
  • Pain relief measured on scale of 0 to 100%.
  • 7% to 37% experienced at least 50% pain relief in the placebo arm (clinical effect)
  • 5% to 63% experienced at least 50% pain relief in the treatment arms (still works better)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Define the Van Laarhoven (2015) Systematic review

A
  • 34 trials of chronic itch (due to atopic dermatitis or psoriasis).
  • Placebo treatment significantly decreased itch (1.3 out of 10, 95% confidence interval 1.02–1.61) compared with baseline itch (effect size 0.55).
  • Placebo effects have a considerable role in these patients’ treatment.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Is the placebo effect;

  • Physiological
  • Psychological
  • Both
A

Both!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the Finnis 2010 Outcome expectancy psychological mechanism of placebos

A
  • Patients given placebo have expectations of future responses.
  • Can be manipulated with verbal cues e.g. by stating whether a treatment is likely to reduce pain.
  • Mediates effects in experimental and clinical pain, motor performance in Parkinson’s disease, changes in emotions, and brain responses in patients with drug addiction.
  • Placebo effects can be stronger depending on the mode of delivery i.e. IV/Injection/Surgery/Tablets
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the Finnis 2010 classical conditioning psychological mechanism for placebo effects

A
  • Repeated associations between neutral stimulus and an active drug (unconditioned stimulus).
  • Neutral stimulus elicits response characteristic of the unconditioned stimulus.
  • Has been demonstrated in both animal and human studies but difficult to exclude any cognitive component (such as expectation) in human beings.
  • More an unconditioned stimulus is paired with a conditioned stimulus, you create a pairing for an outcome i.e. pain reduction.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the neurobiological mechanism involved with the opioid receptors in a placebo effect

A
  • Most research has addressed placebo analgesia.
  • Pain related placebo effects can be completely or partly reversed by the opioid antagonist naloxone.
  • Confirmed with brain imaging techniques such as PET & fMRI.
  • In one PET study, brain changes in response to placebo were reported to be similar to changes seen after with opioid drug.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe this:

A

The middle scan shows there is a neurobiochemical response to placebo treatment, although its not as pronounced as the opioid treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe non-opioid responses to placebos

A
  • Different placebo mechanisms can be produced depending on the drug used in the conditioning protocol.
  • Placebos been shown to change dopamine release in the striatum, basal ganglia and thalamus in patients with Parkinson’s disease.
  • Changes in metabolic activity in the brain after administration of placebo in patients with depression.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Out of placebo aspirin and oxygen mask, which showed a larger improvement on a hypoxic high-altitude headache

A

Larger effect exerted from the oxygen mask- even with placebo the physiological mechanisms were still different.

This means its working at a higher level than just psychological/neurobiological.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What biochemical change was observed with placebo aspirin- hypoxic headache

A

inhibition of cyclo-oxygenase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What biochemical change was observed with placebo oxygen mask- hypoxic headache

A
  • reduced ventilation
  • reduced blood alkalosis
17
Q

Describe what is being observed here

A

Different mechanisms of placebo link to outcomes.

Conscious expectations can lead to lots of effects which equals a placebo effect being experienced.

Very much effected by the way in which its manipulated i.e. mode of delivery or how we’ve learnt that effect

18
Q

Why do placebo effects need to be controlled for in clinical trials?

A
  • When placebo effects are large they cast doubt on the intervention efficacy and on the proposed mechanism of action of the “real” treatment.
  • Is the effect partially or wholly due to psychological – rather than pharmacological processes?
  • Systematic review of 115 studies found no significant difference between treatment and placebo effects (MD= −0.29, 95% CI −0.62 to 0.05, P=0.10)
19
Q

How many arms should a correct placebo controlled trial have?

A
20
Q

Describe the three arms in correct clinical trial design

A

Arm 1: Intervention/treatment

Arm 2: Placebo (matched for “non-specific effects” e.g., setting, communication, credibility, appearance - anything that can affect expectations or motivation. Must be double blind (i.e. to patients and professionals to control for expectations).

Arm 3: No treatment (e.g., waiting list) controls for regression to the mean, spontaneous remission (e.g. practice effects, development of expertise) and unknown parallel interventions

21
Q

Give two factors which could effect placebo effects

A
  • Treatment Characteristics: shape, size and colour of drug
  • Health Care Settings: care at home/ hospital, lay out of, wards etc.
  • Patient Characteristics: beliefs, expectations anxiety levels etc.
  • HCP Characteristics: gender, status, beliefs and job satisfaction
  • HCP-Patient Relations e.g. information provision, reassurance, compassion, changing expectations etc
22
Q

Give two of the BCT taxonomies which could be relevant for placebo effects

A
23
Q

What did the Di Blasi (2001) Systematic Review show regarding placebo effects?

A
  • 25 RCTs
  • 19 manipulated treatment expectancy
  • Mainly cog care but 4 manipulated cognitive and emotional care.
  • Ten found sig effect on health outcomes (2/10 high quality trials).
  • Nine no sig differences (5 high quality trials).
24
Q

What are some potential ethical considerations regarding placebos

A

Rothman, K. J. (1996)

  • Is it ethical to offer patients treatments that have no known beneficial effect even when they consent?
  • Is it ethical to ask patient to consent to placebo treatments that may have damaging effects - e.g. placebo surgery?
  • Is it ethical not to run placebo trials of treatments proposed for widespread use?
25
Q

Can placebos work without deception?

A

Kaptchuk (2010)

  • Two-arm RCT.
  • N = 80 patients with IBS.
  • Arm 1: Pills presented as “placebo pills made of an inert substance that have been shown in clinical studies to produce significant improvement in IBS symptoms through mind-body self-healing processes.”
  • Arm 2: No-treatment controls with the same quality of interaction with providers.
  • Significantly higher mean IBS global improvement scores in arm 1 at 21- day endpoint (p=.002).